Literature DB >> 5806387

The isolation, identification and synthesis of two metabolites of guanethidine formed in pig and rabbit liver homogenates.

F B Abramson, C I Furst, C McMartin, R Wade.   

Abstract

1. Two metabolites of radioactively labelled guanethidine were isolated from rabbit and pig liver homogenates by ion-exchange chromatography on a sulphonic acid resin. 2. One of the metabolites was eluted from the column with ammonia and identified as 2-(6-carboxyhexylamino)ethylguanidine on the basis of the elemental analysis, i.r. spectrum and pH titration curve of the pure compound, and the observed partial loss of tritium for ring-labelled guanethidine during the formation of this metabolite. 3. This identification was confirmed by synthesis. 4. 2-(6-Carboxyhexylamino)ethylguanidine underwent ring-closure in hot alkaline solution to 1-(6-carboxyhexyl)-2-iminoimidazolidine. 5. The other metabolite of guanethidine was eluted from the ion-exchange column with 6m-hydrochloric acid along with the unchanged drug. It was purified by countercurrent distribution and shown to be identical with synthetic guanethidine N-oxide. 6. The two metabolites and the product of ring-closure had less than one-tenth of the antihypertensive activity of guanethidine in the renal-hypertensive rat and are unlikely to contribute to the pharmacological properties of the drug.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5806387      PMCID: PMC1184614          DOI: 10.1042/bj1130143

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  INTERACTION OF GUANETHIDINE WITH ADRENERGIC NEURONS.

Authors:  C C CHANG; E COSTA; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1965-03       Impact factor: 4.030

2.  Enzymatic dealkylation of aminopyrine (pyramidon) and other alkylamines.

Authors:  B N LA DU; L GAUDETTE; N TROUSOF; B B BRODIE
Journal:  J Biol Chem       Date:  1955-06       Impact factor: 5.157

3.  [The relation between the guanethidine concentration in the rat heart and its noradrenalin content].

Authors:  G M BISSON; E MUSHOLL
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1962

4.  Clinical and pharmacological studies with guanethidine in the treatment of hypertension.

Authors:  C T DOLLERY; D EMSLIE-SMITH; M D MILNE
Journal:  Lancet       Date:  1960-08-20       Impact factor: 79.321

5.  Relationship between the lipid solubility of drugs and their oxidation by liver microsomes.

Authors:  L E GAUDETTE; B B BRODIE
Journal:  Biochem Pharmacol       Date:  1959-08       Impact factor: 5.858

6.  Enzymatic pathway for the formation of cotinine, a major metabolite of nicotine in rabbit liver.

Authors:  H B HUCKER; J R GILLETTE; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1960-05       Impact factor: 4.030

7.  Determination of creatine, creatinine, arginine, guanidinoacetic acid, guanidine, and methylguanidine in biological fluids.

Authors:  J HESS; E KITO; R P MARTIN; J F VAN PILSUM
Journal:  J Biol Chem       Date:  1956-09       Impact factor: 5.157

8.  The specificity of arginase: action upon argininic acid.

Authors:  A Hunter; H E Woodward
Journal:  Biochem J       Date:  1941-12       Impact factor: 3.857

9.  The metabolism of tremorine. Identification of a new biologically active metabolite, N-(4-pyrrolidino-2-2-butynyl)-gamma-aminobutyric acid.

Authors:  W Hammer; B Holmstedt; B Karlén; F Sjöqvist; J Vessman
Journal:  Biochem Pharmacol       Date:  1968-09       Impact factor: 5.858

10.  Preliminary studies of the metabolism of 2-guanidinomethyl-1:4-benzodioxan sulphate (guanoxan).

Authors:  A Cãnas-Rodriguez
Journal:  Experientia       Date:  1966-07-15
View more
  3 in total

1.  Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study.

Authors:  H Ogita; T Shimonagata; M Fukunami; K Kumagai; T Yamada; Y Asano; A Hirata; M Asai; H Kusuoka; M Hori; N Hoki
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

2.  Reasons for the occurrence of the twenty coded protein amino acids.

Authors:  A L Weber; S L Miller
Journal:  J Mol Evol       Date:  1981       Impact factor: 2.395

3.  Asymmetry of cardiac [123I] meta-iodobenzyl-guanidine scans in patients with ventricular tachycardia and a "clinically normal" heart.

Authors:  J S Gill; G J Hunter; J Gane; D E Ward; A J Camm
Journal:  Br Heart J       Date:  1993-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.